Spencer J. Johnson
Congress Takes Aim at Reducing the Cost of Medicine
Biosimilars Law Bulletin ·
Uncertain Future for Skinny Labels as Federal Circuit Panel Agrees to Rehearing
Biosimilars Law Bulletin ·
Litigation on Amgen’s Biosimilar to Avastin Settles on Heels of Amgen Procedural Victory at Federal Circuit
Biosimilars Law Bulletin ·
2019 Ends and 2020 Begins with a Flurry of Biosimilar Activity in East Asian Markets
Biosimilars Law Bulletin ·